Pharmacoepidemiology and Drug Safety

Cover image for Vol. 23 Issue 4

April 2014

Volume 23, Issue 4

Pages 331–441

  1. Original Reports

    1. Top of page
    2. Original Reports
    3. Commentary
    4. Original Reports
    5. Brief Report
    6. Original Reports
    7. Commentaries
    8. Letters to the Editor
    1. Cardiovascular and mortality risk in elderly Medicare beneficiaries treated with olmesartan versus other angiotensin receptor blockers (pages 331–339)

      David J. Graham, Esther H. Zhou, Stephen McKean, Mark Levenson, Katlyn Calia, Kate Gelperin, Xiao Ding, Thomas E. MaCurdy, Chris Worrall and Jeffrey A. Kelman

      Version of Record online: 26 NOV 2013 | DOI: 10.1002/pds.3548

    2. Cardiac mortality in users of olmesartan, other angiotensin-receptor blockers and angiotensin-converting enzyme inhibitors (pages 348–356)

      Alexander M. Walker, Caihua Liang, C. Robin Clifford, Crawford Parker and Allen Feldman

      Version of Record online: 23 DEC 2013 | DOI: 10.1002/pds.3558

  2. Commentary

    1. Top of page
    2. Original Reports
    3. Commentary
    4. Original Reports
    5. Brief Report
    6. Original Reports
    7. Commentaries
    8. Letters to the Editor
  3. Original Reports

    1. Top of page
    2. Original Reports
    3. Commentary
    4. Original Reports
    5. Brief Report
    6. Original Reports
    7. Commentaries
    8. Letters to the Editor
    1. You have full text access to this OnlineOpen article
      Safety analysis of Ziagen® (abacavir sulfate) in postmarketing surveillance in Japan (pages 361–371)

      Tomoko Kurita, Tomomi Kitaichi, Takako Nagao, Toshiyuki Miura and Yoshifumi Kitazono

      Version of Record online: 3 MAR 2014 | DOI: 10.1002/pds.3589

    2. You have full text access to this OnlineOpen article
      Safety analysis of Epzicom® (lamivudine/abacavir sulfate) in post-marketing surveillance in Japan (pages 372–381)

      Tomoko Kurita, Tomomi Kitaichi, Takako Nagao, Toshiyuki Miura and Yoshifumi Kitazono

      Version of Record online: 3 MAR 2014 | DOI: 10.1002/pds.3588

    3. Differences among admitting departments in alerts and alert overrides for drug–drug interaction (pages 390–397)

      Eun Kyoung Ahn, Hye Jin Kam, Dong Kyun Park, Eun Young Jung, Youngho Lee and Rae Woong Park

      Version of Record online: 21 FEB 2014 | DOI: 10.1002/pds.3591

    4. You have full text access to this OnlineOpen article
  4. Brief Report

    1. Top of page
    2. Original Reports
    3. Commentary
    4. Original Reports
    5. Brief Report
    6. Original Reports
    7. Commentaries
    8. Letters to the Editor
    1. Guideline-recommended use of asthma medication by children is associated with parental information and knowledge: the PIAMA birth cohort (pages 406–410)

      Alet H. Wijga, Mira G. P. Zuidgeest, Marjan Kerkhof, Gerard H. Koppelman, Henriëtte A. Smit and Johan C. de Jongste

      Version of Record online: 12 FEB 2014 | DOI: 10.1002/pds.3584

  5. Original Reports

    1. Top of page
    2. Original Reports
    3. Commentary
    4. Original Reports
    5. Brief Report
    6. Original Reports
    7. Commentaries
    8. Letters to the Editor
    1. You have full text access to this OnlineOpen article
    2. Impact of a drug utilization review program on high-risk use of prescription controlled substances (pages 419–427)

      Matthew Daubresse, Patrick P. Gleason, Yi Peng, Nilay D. Shah, Stephen T. Ritter and G. Caleb Alexander

      Version of Record online: 24 JUL 2013 | DOI: 10.1002/pds.3487

  6. Commentaries

    1. Top of page
    2. Original Reports
    3. Commentary
    4. Original Reports
    5. Brief Report
    6. Original Reports
    7. Commentaries
    8. Letters to the Editor
    1. The European Medicines Agency's use of prioritised independent research for best evidence in regulatory action on diclofenac (pages 431–434)

      Peter Arlett, Sinan B. Sarac, Andrew Thomson, Claire Davies, Tania Teixeira, Kevin V. Blake and Doris Stenver

      Version of Record online: 25 FEB 2014 | DOI: 10.1002/pds.3594

  7. Letters to the Editor

    1. Top of page
    2. Original Reports
    3. Commentary
    4. Original Reports
    5. Brief Report
    6. Original Reports
    7. Commentaries
    8. Letters to the Editor
    1. Response to Cunill et al. (pages 435–436)

      J. Antoni Ramos-Quiroga, Pedro Lopez-Romero and Chris Bushe

      Version of Record online: 5 APR 2014 | DOI: 10.1002/pds.3572

    2. Reply to the letter to the editor by Ramos-Quiroga et al. (pages 437–438)

      R. Cunill, X. Castells, A. Tobias and D. Capellà

      Version of Record online: 5 APR 2014 | DOI: 10.1002/pds.3570

SEARCH

SEARCH BY CITATION